According to a statement from GlobalData, “the global breast imaging market to reach $4.7 billion by 2025, fueled by technological advancements and growing awareness of breast cancer screening.”
They say, “The broader diagnostic imaging market is projected to grow to $38.9 billion by 2027 at a 5.1% CAGR during 2024-27, driven by the demand for advanced imaging technologies like full-field digital mammography.”
Seno Medical was awarded a contract from Vizient for its Imagio breast imaging system in November 2024. GlobalData described this contract as a “significant advancement” that will “help transform breast cancer diagnostics.”
The Imagio system reduces the need for invasive biopsies by combining “opto-acoustic and ultrasound imaging to provide real-time, non-invasive insights into breast masses.”
